Company · CIK 0000932352
Vaneltix Pharma, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Jun 30
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- S-1IPO registration0001144204-15-008021 · 3.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001013762-12-001903 · 35.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001013762-12-001809 · 24.0 KBSEC(opens sec.gov)
- 10-KAnnual report0001013762-12-001571 · 3.6 MBSEC(opens sec.gov)
- 8-KCurrent report0001013762-12-001292 · 32.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001013762-12-000046 · 833.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001013762-10-002181 · 24.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001013762-10-001541 · 42.7 KBSEC(opens sec.gov)
- 10-QQuarterly update0001013762-10-001182 · 742.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001013762-10-001008 · 445.7 KBSEC(opens sec.gov)
Insiders
- ALTSCHUL ARTHUR G JR10% Owner
- DELTA OPPORTUNITY FUND LTD10% Owner
- DIAZ & ALTSCHUL CAPITAL MANAGEMENT LLC10% Owner
- DIAZ REINALDO MDirector
- ENRIGHT PATRICK GDirector
- Garner William JDirector, Chief Executive Officer, 10% Owner
- GOLDBERG MICHAEL MDirector
- GREAT POINT PARTNERS LLC10% Owner
- JAY JEFFREY R10% Owner
- LASEZKAY GEORGE MDirector
Tickers
No tickers on record.
Addresses
business
317 GEORGE STREET SUITE 400
NEW BRUNSWICK, NJ, 08901
mailing
317 GEORGE STREET SUITE 400
NEW BRUNSWICK, NJ, 08901
Former names
- Urigen Pharmaceuticals, Inc.2020-11-20
- VALENTIS INC2007-07-31
- MEGABIOS CORP1999-02-24
Same industry